Prospective Memory in Parkinson's Disease
Trial
N/A
Completed
May 5, 2022
Feasibility of Motor-cognitive Home Training for Parkinson's Disease Using eHealth Technology
Trial
N/A
Completed
May 3, 2022
Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
Trial
N/A
Completed
May 3, 2022
Study of OXB-102 (AXO-Lenti-PD) in Patients With Bilateral, Idiopathic Parkinson's Disease
Trial
Phase 1
Terminated
May 2, 2022
Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease
Trial
Phase 1
Terminated
May 2, 2022
Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease
Trial
Phase 2
Completed
May 2, 2022
Efficacy of Oral Administration of Trehalose in Patients With Parkinson Disease
Trial
Phase 4
Unknown
May 1, 2022
tDCS of the Primary Motor Cortex to Improve Implicit Motor Sequence Learning in Parkinson's Disease
Trial
N/A
Unknown
May 1, 2022
Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients
Trial
Phase 2
Completed
April 28, 2022
Investigating the Use of Complex Pulse Shapes for DBS in Movement Disorders
Trial
N/A
Completed
April 28, 2022
Action Observation Therapy and Mirror Therapy in Parkinson's Disease
Trial
N/A
Unknown
April 27, 2022
Health Indicators and Patient Reported Outcomes. Identification of Significative Items Aimed at Improving Health Care Procceses.
Trial
N/A
Unknown
April 26, 2022
Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases
Trial
N/A
Withdrawn
April 25, 2022
Phenylbutyrate Response as a Biomarker for Alpha-synuclein Clearance From the Brain
Trial
Phase 1
Completed
April 24, 2022
Parkinson's Disease in Home Rehabilitation Services
Trial
N/A
Completed
April 21, 2022
Characterizing Biomarkers of Early Parkinson's Disease Progression (TREG)
Trial
N/A
Terminated
April 19, 2022
SIS Evaluation of the MRI Defined Subthalamic Nucleus*
Trial
N/A
Terminated
April 18, 2022
High Frequency Oscillations in Neurologic Disease
Trial
Phase 1
Completed
April 14, 2022
Study of Zonisamide in Early Parkinson Disease
Trial
Phase 2
Withdrawn
April 13, 2022
Effects of Visual Biofeedback Therapy in Parkinson's Patients
Trial
N/A
Unknown
April 12, 2022